Elutia, Inc. (ELUT)
1.05
+0.10
(+10.38%)
USD |
NASDAQ |
Feb 13, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Elutia EPS Diluted (Quarterly) : -0.1909 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Teleflex, Inc. | -9.243 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.383M |
| Revenue (Quarterly) | 3.323M |
| Total Expenses (Quarterly) | 3.706M |
| Enterprise Value | 78.66M |
| Gross Profit Margin (Quarterly) | 55.76% |
| Profit Margin (Quarterly) | -11.53% |
| Earnings Yield | -87.56% |
| Normalized Earnings Yield | -90.97 |